Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLuceco Plc Regulatory News (LUCE)

Share Price Information for Luceco Plc (LUCE)

Share Price is delayed by 15 minutes
Get Live Data
267.00    -3.00 (-1.11%)
Bid:
265.00
Ask:
274.00
Spread: 9.00 (3.396%)
Market Cap: £393.00m
LUCE Live PriceLast checked at - London Stock Exchange

Intraday Luceco Plc Share Chart

Holding(s) in Company

8 Jun 2021 10:15

RNS Number : 1661B
Luceco PLC
08 June 2021
Β 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BZC0LP49

Issuer Name

LUCECO PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Asset Management Holdings Inc.

City of registered office (if applicable)

Wilmington

Country of registered office (if applicable)

United States of America

4. Details of the shareholder

Name

City of registered office

Country of registered office

JPMorgan Asset Management (UK) Limited

5. Date on which the threshold was crossed or reached

04-Jun-2021

6. Date on which Issuer notified

07-Jun-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.229762

0.146598

5.376360

8645194

Position of previous notification (if applicable)

4.981663

0.146598

5.128261

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BZC0LP49

8409464

5.229762

Sub Total 8.A

8409464

5.229762%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash-settled Equity Swap

n/a

n/a

Cash

235730

0.146598

Sub Total 8.B2

235730

0.146598%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Asset Management Holdings Inc

JPMorgan Asset Management (UK) Limited

5.229762

0.146598

5.376360

10. In case of proxy voting

Name of the proxy holder

Β 

The number and % of voting rights held

Β 

The date until which the voting rights will be held

Β 

11. Additional Information

Chain of controlled undertakings:JPMorgan Asset Management Holdings Inc. (100%)JPMorgan Asset Management International Limited (100%)JPMorgan Asset Management (UK) Limited (100%)

12. Date of Completion

07-Jun-2021

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
HOLUWAKRASUNRRR
Date   Source Headline
28th May 20262:56 pmRNSHolding(s) in Company
27th May 20265:56 pmRNSDirector/PDMR Shareholding
27th May 20262:41 pmRNSDirector/PDMR Shareholding
22nd May 20261:16 pmRNSHolding(s) in Company
19th May 20263:35 pmRNSResult of AGM
19th May 20267:00 amRNSQ1 2026 Trading Update
7th May 20263:08 pmRNSDirector/PDMR Shareholding
27th Apr 202611:14 amRNSMarket Purchase of Shares for EBT
24th Apr 20266:03 pmRNSHolding(s) in Company
20th Apr 20264:18 pmRNSNotice of AGM
20th Apr 20267:01 amRNSDirector Declaration
9th Apr 20265:20 pmRNSDirector/PDMR Shareholding
31st Mar 20265:29 pmRNSChange in Directorate Roles and Responsibilities
25th Mar 20267:00 amRNS2025 Full Year Results
19th Feb 20265:54 pmRNSHolding(s) in Company
17th Feb 20263:58 pmRNSHolding(s) in Company
13th Feb 20265:30 pmRNSHolding(s) in Company
13th Feb 20267:00 amRNSAppointment of Joint Corporate Broker
9th Feb 202612:03 pmRNSDirector/PDMR Shareholding
9th Feb 202611:11 amRNSHolding(s) in Company
29th Jan 20267:00 amRNS2025 Full Year Trading Update
9th Dec 20254:00 pmRNSAppointment of Non-Executive Director
8th Dec 20254:30 pmRNSHolding(s) in Company
4th Dec 20255:00 pmRNSHolding(s) in Company
12th Nov 20255:00 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSQ3 2025 Trading Update
23rd Oct 20252:10 pmRNSHolding(s) in Company
21st Oct 20254:34 pmRNSHolding(s) in Company
7th Oct 20253:53 pmRNSHolding(s) in Company
15th Sep 20255:00 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS2025 Interim Results
6th Aug 20254:08 pmRNSHolding(s) in Company
5th Aug 20254:19 pmRNSHolding(s) in Company
5th Aug 20254:17 pmRNSDirector/PDMR Shareholding
5th Aug 20251:08 pmRNSHolding(s) in Company
23rd Jul 20253:59 pmRNSHolding(s) in Company
22nd Jul 20257:00 amRNSH1 2025 Trading Update
21st Jul 20254:31 pmRNSAppointment of Audit Committee Chair
8th Jul 20253:49 pmRNSDirector Declaration
28th May 20255:30 pmRNSDirector/PDMR Shareholding
20th May 20251:55 pmRNSResult of AGM
20th May 20257:00 amRNSQ1 2025 Trading Update
16th May 20253:41 pmRNSHolding(s) in Company
14th May 20254:43 pmRNSHolding(s) in Company
8th May 20259:50 amRNSDirector/PDMR Shareholding
15th Apr 202511:21 amRNSNotice of AGM
11th Apr 20254:34 pmRNSDirector/PDMR Shareholding
9th Apr 20253:35 pmRNSGrant of Awards Under Performance Share Plan
26th Mar 20257:00 amRNS2024 Full Year Results
11th Mar 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.